儿童神经内分泌类癌肿瘤:诊断影像表现与近期进展综述
儿童神经内分泌肿瘤(含类癌)发病率近几十年上升但生存率未显著改善,早期检出对改善临床结局至关重要。本文综述CT、MRI等解剖影像及靶向生长抑素受体的111In-奥曲肽和68Ga标记放射性示踪剂等功能影像(含PET/CT、PET/MRI融合)在儿童类癌检出中的应用。功能影像与解剖影像融合显著提高了类癌的临床检出,但新影像方法和放射性示踪剂治疗在儿童人群中的诊断价值尚需进一步研究。
要点
- 儿童类癌虽罕见但确实存在,影像科医生应熟悉各类检查方法的合理应用。
- 靶向生长抑素受体的功能影像(111In-奥曲肽及68Ga标记示踪剂)与解剖影像融合可提高检出。
- 新影像方法与放射性示踪剂治疗在儿童人群中的诊断价值尚需进一步研究。
核心结论
- 功能影像的进步(新型生长抑素受体特异性放射性示踪剂)结合功能与解剖影像融合,已大幅提高类癌肿瘤的临床检出。
- 儿童中确实会遇到类癌肿瘤,儿科专科医生必须了解各种影像方法的合理使用。
- 尚需进一步研究以明确较新影像方法和基于放射性示踪剂的治疗方法(尤其在儿童人群)的诊断价值。
研究设计与样本
- 综述,讨论儿童类癌肿瘤的影像检测方法,包括CT和MRI等解剖影像方法以及靶向生长抑素受体的功能影像方法(111In标记奥曲肽和较新的68Ga基放射性示踪剂,可用于PET/CT或PET/MRI融合)。
临床应用与阅片要点
- 作者指出,了解各种影像方法的合理使用对儿科专科医生至关重要。
- 作者提出,功能影像与解剖影像融合可提高类癌肿瘤的临床检出。
- 作者认为,尚需进一步研究以明确较新影像方法和基于放射性示踪剂的治疗方法在儿童人群中的诊断价值。
局限性
- 原文指出,尚需进一步研究以明确较新影像方法和基于放射性示踪剂的治疗方法(尤其在儿童人群)的诊断价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Although rare, pediatric neuroendocrine tumors including carcinoid tumor have increased in incidence over the past few decades. Despite increased recognition, survival rates have not significantly improved. Earlier detection of these tumors is necessary to improve clinical outcomes. This article discusses imaging approaches for detecting pediatric carcinoid tumors including anatomic imaging methods such as CT and MRI as well as functional imaging methods targeting the somatostatin receptor including 111In-labeled octreotide and newer 68Ga-based radiotracers that may hold promise in hybrid PET/CT or PET/MRI.
CONCLUSION: Improvements in functional imaging with novel somatostatin receptor-specific radiotracers along with fused functional and anatomic imaging have substantially improved the clinical detection of carcinoid tumors. Although rare, these tumors are encountered in children, and an awareness of the appropriate use of various imaging methods is essential for pediatric specialists. Further research is needed to ascertain the diagnostic value of newer imaging methods and radiotracer-based treatment approaches, especially in the pediatric population.
引用
- Degnan AJ, Tadros SS, Tocchio S, et al. Pediatric Neuroendocrine Carcinoid Tumors: Review of Diagnostic Imaging Findings and Recent Advances. AJR Am J Roentgenol. 2017. PMID: 28199138. doi:10.2214/AJR.16.17287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。